Intracranial arterial dissection is considered to be not a rare disease recently, but the natural history of this disease is not well known yet. In this study, we analyzed the serial changes of angiographical or MRI/MRA finding and the long-term outcome to clarify the treatment strategy in patients with non-hemorrhagic intracranial arterial dissection.
--
These results were quite similar to those in the nationwide study, and suggest that conservative treatment, mainly the control of high blood pressure, is the first choice in the non-hemorrhagic arterial dissection of the vertebrobasilar system and that antiplatelet or anticoagulant therapy might not be indicated in the patient with ischemia. Furthermore, the surgical indication for this disease remains controversial, and the study of a larger number of patients is indispensable to clarify this issue. 
